Pathologic complete response and overall survival in breast cancer subtypes in stage III inflammatory breast cancer

Dominique J. P. van Uden,Marissa C. van Maaren,Peter Bult,L.J.A. Strobbe,J. J. M. van der Hoeven,C.F.J.M. Blanken-Peeters,Sabine Siesling,Johannes H. W. de Wilt

Pathologic complete response and overall survival in breast cancer subtypes in stage III inflammatory breast cancer

2019

Dominique J. P. van Uden
Marissa C. van Maaren
Peter Bult
L.J.A. Strobbe
J. J. M. van der Hoeven
C.F.J.M. Blanken-Peeters
Sabine Siesling
Johannes H. W. de Wilt

Purpose To analyze the influence of hormone receptors (HR) and Human Epidermal growth factor Receptor-2 (HER2)-based molecular subtypes in stage III inflammatory breast cancer (IBC) on tumor characteristics, treatment, pathologic response to neoadjuvant chemotherapy (NACT), and overall survival (OS).

Keywords:

Breast cancer
Cancer research
Human epidermal growth factor
Pathologic Response
Hormone receptor
Inflammatory breast cancer
Medicine
Chemotherapy
Epidemiology
overall survival
complete response

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations